CLOONAN MICHAEL (President & CEO) received a stock award from SIONNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/18/2026ACC: 0001704336-26-000005
DirectorOfficer· President & CEO
Since Feb 2025
+218.05K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
654.15K acquired · 436.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+109.03K
Price / share
—
Trade value
—
% of position
19.9%
9/17/2026
547.34K→656.37K
Common Stock
Direct
Shares
+109.03K
Price / share
—
Trade value
—
% of position
16.6%
9/17/2026
656.37K→765.39K
Total
Net shares
+218.05K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/17/2026 | A · Award | +109.03K | — | — | 19.9% | 547.34K | 656.37K |
| Common Stock Direct | 9/17/2026 | A · Award | +109.03K | — | — | 16.6% | 656.37K | 765.39K |
| Total | +218.05K | $0.00 | ||||||
Derivative Transactions2
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
436.10K shares
Shares
+436.10K
Strike price
7.18
Held after
436.10K
Exercisable
—
9/17/2026
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
436.10K shares
Shares
−436.10K
Strike price
39.21
Held after
0.00
Exercisable
—
9/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock436.10K shares | 9/17/2026 | A · Award | +436.10K | 7.18 | — | 436.10K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock436.10K shares | 9/17/2026 | D · Disposition | −436.10K | 39.21 | — | 0.00 |